J&J asks WHO for approval of its vaccine against COVID-19

Johnson & Johnson has applied to the World Health Organization for approval of its COVID-19 vaccine for emergency use, which should help accelerate its use in countries around the world.

J&J said Friday that its Janssen-Cilag International subsidiary has submitted the latest necessary data from clinical trials on the efficacy and safety of its vaccine to the WHO, completing the New Brunswick, NJ-based company’s application for endorsement. for emergency use.

The approval would expedite access to J & J’s single-dose vaccine for United Nations procurement agencies and dozens of countries. It is also required for Johnson & Johnson to supply doses of its vaccine to the COVAX Mechanism, a WHO-backed project to ensure equitable access to vaccines for some 190 low- and middle-income countries. In December, Johnson & Johnson agreed to provide up to 500 million doses of its vaccine to COVAX through 2022.

“If we want to end the pandemic, life-saving innovations such as vaccines must be available to all countries,” said Dr. Paul Stoffels, Johnson & Johnson’s chief scientific officer, in a statement.

The company will supply the vaccine at non-profit prices during the acute phase of the pandemic.

In addition to requiring a single dose, the J&J vaccine can be stored for at least three months at normal refrigerator temperature, making it a good choice for poor and rural areas and for developing countries that lack infrastructure. for extremely cold storage required by other COVID-19 vaccines.

Interim results from an advanced phase trial with 44,000 volunteers revealed that Johnson & Johnson’s vaccine was 66% effective in preventing moderate and severe COVID-19 cases in Latin America and 57% in South Africa, where it is spreading a more contagious variant. In the United States, the efficacy was 72%.

The tests also indicated that the vaccine was 85% protective against the most severe symptoms, and starting 28 days after the injection, the researchers found that no one who was vaccinated required hospitalization or died.

READ  Obstacles on the way to the post-covid-19 city

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.